All articles tagged with #mplx
MPLX and Fidus Investment are rated Buy for durable, high‑yield income portfolios: MPLX offers a 7.4% yield with about 12.5% expected annual distribution growth underpinned by fee-based contracts and energy projects, while FDUS yields 11.8% and trades around a 10% discount to NAV with a disciplined, resilient first‑lien loan book and low non‑accruals; together they provide immediate diversification and strong long‑term total return potential.
MPLX and Omega Healthcare Investors are two high-yield dividend stocks offering attractive opportunities for passive income investors. MPLX, a master limited partnership, provides a 7.8% yield with a strong growth pipeline, while Omega Healthcare Investors, a healthcare REIT, offers a 6.7% yield with stable income. Both stocks are appealing for income-seeking investors due to their potential for higher returns compared to similar investments.
Microsoft, Starbucks, and MPLX are poised to increase their dividend payouts in 2024. Microsoft has a history of strong dividend growth, fueled by its robust cash flow and growth drivers in gaming and AI. Starbucks, with its Triple Shot Reinvention strategy, aims to drive revenue and earnings growth, potentially leading to accelerated dividend growth. Meanwhile, MPLX, with a high yield and solid financial foundation, is expected to continue increasing its distribution. These stocks present compelling options for investors seeking rapidly rising income streams.
Jim Cramer advises investors to sell one third of their Celestica stock, describing it as a "very dicey situation," while expressing positive views on MPLX's pipelines and caution regarding buying Taiwan Semiconductor stock.